Vanguard Group Inc Ovid Therapeutics Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding OVID
# of Institutions
82Shares Held
43.2MCall Options Held
5.9KPut Options Held
300-
Eco R1 Capital, LLC San Francisco, CA6.12MShares$4.59 Million0.53% of portfolio
-
Rubric Capital Management LP New York, NY5.32MShares$3.99 Million0.55% of portfolio
-
Black Rock Inc. New York, NY4.2MShares$3.15 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$2.89 Million0.35% of portfolio
-
Madison Avenue Partners, LP New York, NY3.65MShares$2.74 Million2.22% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $52.8M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...